HOME >> MEDICINE >> NEWS
Emory conference to educate health professionals about 'metabolic syndrome'

An estimated 25 percent of adults over the age of 20 and close to 50 percent of adults over the age of 50 have the component risk factors that make up Metabolic Syndrome. The emerging health problem is the focus of a symposium for health professionals on Friday, May 21, hosted by the Emory University School of Medicine.

Thirteen nationally recognized experts on this increasingly common disorder will present at a daylong conference called "Metabolic Syndrome: An Obesity-Related National Epidemic---Mechanisms, Clinical Care and Future Directions. The event is CME-accredited and will include session topics on the clinical characteristics, pathogenesis and treatment of the metabolic syndrome, its associated conditions, and future research directions. It will be held from 8:00 a.m. to 5:15 p.m. in the auditorium of the Woodruff Health Sciences Center Administration Building on the Emory campus at 1440 Clifton Road.

Metabolic Syndrome, also known as Syndrome X, is a clustering of cardiovascular disease risk factors that is highly linked to obesity. It causes an increased risk of coronary heart disease, type 2 diabetes, and other diseases related to plaque buildups in artery walls, such as stroke and peripheral vascular disease. The diagnosis of the condition is based on the presence of three or more cardiovascular disease risk factors, including increased abdominal fat, pre-diabetes, high blood pressure, evidence of mild generalized inflammation, low blood levels of "good" cholesterol (HDL cholesterol) and/or high blood levels of triglycerides (circulating fats in the blood).

"The actual criteria for diagnosis of Metabolic Syndrome are still being debated by researchers," says Thomas R. Ziegler, M.D., associate professor of medicine, Department of Medicine, and director of the Emory Center for Clinical and Molecular Nutrition. "For example, some criteria include abnormalities such as a tendency for easy blood clotting and evidence of oxidative
'"/>

Contact: Tia Webster
twebste@emory.edu
404-727-5692
Emory University Health Sciences Center
13-May-2004


Page: 1 2 3

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
5. Emory researchers find race and gender gaps in treatment of heart attack
6. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
7. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
8. Emory scientists find marker for long-term immunity
9. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
10. Emory scientists link atrial fibrillation with decrease in nitrous oxide
11. Immune memory from smallpox vaccination lasts more 50 years, according to Emory research

Post Your Comments:
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... innovative True Form Tummy Tuck® method as ... at The University of Texas Medical Branch in ... medical student. Patronella, who is a founding partner of ... in Texas, The Aesthetic Center for Plastic Surgery ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
(Date:10/20/2014)... --  BioNano Genomics announced today achievement of a major ... data at 30X depth, sufficient for a genome map, in ... established and demonstrated for the IrysChip TM V2, the ... and will be rolled out to BioNano,s collaborators and customers ... advancement at the American Society for Human Genetics (ASHG) ...
(Date:10/20/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, received official notification from the European Patent Office ... patent supporting its iSONEP™ and ASONEP™ programs. ... No. 2087002, claims compositions of matter related to ... compounds, iSONEP and ASONEP. Sonepcizumab is an antibody ...
(Date:10/20/2014)... Norgine B.V. today announced that the Phase ... NER1006, presented at the 79 th Annual Scientific ... Philadelphia, PA , has met its primary ... of cleansing success. The study demonstrated high quality bowel ... screening colonoscopy patients. [1] (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a) ...
Breaking Medicine Technology:BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
Cached News: